Cargando…

Knowledge gap in a cross section of Irish general practitioners prescribing denosumab for osteoporosis

BACKGROUND: Denosumab is commonly used by general practitioners (GPs) in Ireland to treat osteoporosis though drug holidays are not recommended with rebound bone loss and risk of vertebral fractures if stopped. We aimed to investigate GP practice and knowledge regarding denosumab including use and r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reilly, Eimear O’, Fitzpatrick, Donal, Lannon, Rosaleen, McCarroll, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200694/ https://www.ncbi.nlm.nih.gov/pubmed/37211588 http://dx.doi.org/10.1007/s11845-023-03383-w

Ejemplares similares

The use of postal audit and feedback among Irish General Practitioners for the self – management of antimicrobial prescribing: a qualitative study
por: Roche, Kevin F., et al.
Publicado: (2022)

Denosumab for the treatment of osteoporosis
por: McClung, Michael R.
Publicado: (2017)

Over prescribing of antibiotics for acute respiratory tract infections; a qualitative study to explore Irish general practitioners’ perspectives
por: O’Doherty, Jane, et al.
Publicado: (2019)

Knowledge is power: general practitioners prescribing of new oral anticoagulants in Ireland
por: Murphy, A., et al.
Publicado: (2018)

Osteoporosis in men: epidemiology and treatment with denosumab
por: Sidlauskas, Kristel M, et al.
Publicado: (2014)

A review of denosumab for the treatment of osteoporosis
por: Miyazaki, Tsuyoshi, et al.
Publicado: (2014)

The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture—results of a large observational cohort study
por: Fitzpatrick, Donal, et al.
Publicado: (2023)

Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia
por: Růžičková, Olga, et al.
Publicado: (2018)

Emerging treatments for postmenopausal osteoporosis – focus on denosumab
por: Geusens, Piet
Publicado: (2009)

Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2011)

Denosumab: an investigational drug for the management of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2008)

Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
por: Min, Yong-Ki
Publicado: (2015)

Alopecia areata after denosumab treatment for osteoporosis
por: Lyakhovitsky, Anna, et al.
Publicado: (2016)

Osteoporosis Therapy With Denosumab in Organ Transplant Recipients
por: Brunova, Jana, et al.
Publicado: (2018)

Persistence of Denosumab Therapy among Patients with Osteoporosis
por: Kobayashi, Kazuyoshi, et al.
Publicado: (2020)

Should denosumab treatment for osteoporosis be continued indefinitely?
por: Noble, Jane A., et al.
Publicado: (2021)

Denosumab versus romosozumab for postmenopausal osteoporosis treatment
por: Kobayakawa, Tomonori, et al.
Publicado: (2021)

Efficacy of Denosumab for Osteoporosis in Patients with Rheumatic Diseases
por: Kaneko, Kaichi, et al.
Publicado: (2022)

The efficacy of denosumab in Korean male patients with osteoporosis
por: Jeong, Chaiho, et al.
Publicado: (2022)

Denosumab, an effective osteoporosis treatment option for men
por: Kong, Sung Hye
Publicado: (2022)

Long-term consequences of osteoporosis therapy with denosumab
por: Bandeira, Francisco, et al.
Publicado: (2022)

Irish general practitioners' view of perinatal mental health in general practice: a qualitative study
por: Noonan, Maria, et al.
Publicado: (2018)

Assessment of antibiotic prescribing in Latvian general practitioners
por: Dumpis, Uga, et al.
Publicado: (2013)

Prescribing Behavior of General Practitioners for Generic Drugs
por: Tuncay, Berna, et al.
Publicado: (2020)

Knowledge, attitudes, and practices of General Practitioners from the Province of Parma (Northern Italy) towards vaccinations in adults ≥65 year-old
por: Vezzosi, Luigi, et al.
Publicado: (2019)

Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain
por: Darbà, Josep, et al.
Publicado: (2015)

Denosumab – a new medication in the treatment of postmenopausal osteoporosis
por: Słopień, Radosław, et al.
Publicado: (2017)

Denosumab for dialysis patients with osteoporosis: A cohort study
por: Kunizawa, Kyohei, et al.
Publicado: (2020)

Treatment of osteoporosis with denosumab in patients with decreased kidney function
por: Svendsen, Ole Lander
Publicado: (2023)

Knowledge on Osteoporosis of Prescriber According to Level of Medical Institute
por: Yoon, Byung-Ho, et al.
Publicado: (2014)

Outpatient Antibiotic Prescribing Among United States Nurse Practitioners and Physician Assistants
por: Sanchez, Guillermo V., et al.
Publicado: (2016)

Does continuing professional development enhance patient care? A survey of Irish based general practitioners: Successful implementation of mandatory CPD in Irish General Practice
por: McBride, Adam, et al.
Publicado: (2022)

Improving Knowledge of General Dental Practitioners on Antibiotic Prescribing by Raising Awareness of the Faculty of General Dental Practice (UK) Guidelines
por: Zahabiyoun, Sana, et al.
Publicado: (2015)

A randomized placebo-controlled trial of the efficacy of denosumab in Indian postmenopausal women with osteoporosis
por: Pitale, Shailesh, et al.
Publicado: (2015)

Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
por: Anastasilakis, Athanasios D, et al.
Publicado: (2012)

Update on denosumab in the management of postmenopausal osteoporosis: patient preference and adherence
por: Cairoli, Elisa, et al.
Publicado: (2015)

Efficacy of denosumab in two cases with multiple-system atrophy and osteoporosis
por: Uehara, Masashi, et al.
Publicado: (2018)

Are women with osteoporosis treated with denosumab at risk of severe COVID-19?
por: Formenti, Anna Maria, et al.
Publicado: (2020)

Effects of denosumab treatment in chronic liver disease patients with osteoporosis
por: Saeki, Chisato, et al.
Publicado: (2020)

Real World Experience of Denosumab Treatment in the Belfast Osteoporosis Service
por: Moran, CP, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1qioj8esa5d5bih3e4bkh2t92v